Citation: S. Gundersen et al., A RETROSPECTIVE STUDY OF THE VALUE OF CHEMOTHERAPY AS ADJUVANT THERAPY TO SURGERY AND RADIOTHERAPY IN GRADE-3 AND GRADE-4 GLIOMAS, European journal of cancer, 34(10), 1998, pp. 1565-1569
Authors:
LOTE K
STENWIG AE
SKULLERUD K
HIRSCHBERG H
Citation: K. Lote et al., PREVALENCE AND PROGNOSTIC-SIGNIFICANCE OF EPILEPSY IN PATIENTS WITH GLIOMAS, European journal of cancer, 34(1), 1998, pp. 98-102
Authors:
LOTE K
EGELAND T
HAGER B
STENWIG B
SKULLERUD K
BERGJOHNSEN J
STORMMATHISEN I
HIRSCHBERG H
Citation: K. Lote et al., SURVIVAL, PROGNOSTIC FACTORS, AND THERAPEUTIC EFFICACY IN LOW-GRADE GLIOMA - A RETROSPECTIVE STUDY IN 379 PATIENTS, Journal of clinical oncology, 15(9), 1997, pp. 3129-3140
Citation: S. Gundersen et al., PROGNOSTIC FACTORS FOR GLIOBLASTOMA-MULTIFORME - DEVELOPMENT OF A PROGNOSTIC INDEX, Acta oncologica, 35, 1996, pp. 123-127
Authors:
ABRAHAMSEN JF
SMAALAND R
SANDBERG S
AAKVAAG A
LOTE K
Citation: Jf. Abrahamsen et al., CIRCADIAN VARIATION IN SERUM CORTISOL AND CIRCULATING NEUTROPHILS AREMARKERS FOR CIRCADIAN VARIATION OF BONE-MARROW PROLIFERATION IN CANCER-PATIENTS, European journal of haematology, 50(4), 1993, pp. 206-212
Citation: R. Smaaland et al., DNA-SYNTHESIS AND PLOIDY IN NON-HODGKINS-LYMPHOMAS DEMONSTRATE INTRAPATIENT VARIATION DEPENDING ON CIRCADIAN STAGE OF CELL SAMPLING, Cancer research, 53(13), 1993, pp. 3129-3138